WHO ICTRP trial
A Study to Learn About if the Study Medicine Called Ibuzatrelvir changes how the…
CTIS2024-517797-14-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-517797-14-00 |
|---|---|
| Public title | A Study to Learn About if the Study Medicine Called Ibuzatrelvir changes how the body process the other Medicine Dabigatran Etexilate in healthy adults |
| Scientific title | - C5091010 |
| Primary sponsor | Pfizer Inc. |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Belgium |
| Conditions | severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) MedDRA version: 23.0Level: PTClassification code: 10084268Term: COVID-19 Class: 100000004862 MedDRA version: 23.0Level: LLTClassification code: 10084272Term: SARS-CoV-2 infection… |
| Registration date | Jan 10, 2024 |
| Target size | 20 |
| Registry page | euclinicaltrials.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: